Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human IMP1-associated desert definitive endoderm long non-coding RNA (HIDEN, also known as IGF2BP1 associated definitive endoderm lncRNA or IADEN) is a cytoplasmic long non-coding RNA specifically upregulated during differentiation of human pluripotent stem cells into definitive endoderm. HIDEN does not affect the maintenance of pluripotency but is required for successful transition to definitive endoderm. Mechanistically, HIDEN interacts with the RNA-binding protein IGF2BP1 (IMP1), facilitating the binding of IGF2BP1 to FZD5 mRNA and promoting its stability. Stabilization of FZD5, a WNT signaling receptor, enhances WNT pathway activity, which is necessary for definitive endoderm differentiation. Depletion of HIDEN impairs endoderm differentiation by destabilizing FZD5 mRNA and reducing WNT signaling. HIDEN, as a "desert" lncRNA (a lncRNA from a gene desert region), is notable because such RNAs are less well characterized but may play unique regulatory roles in cell fate decisions[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human IMP1-associated desert definitive endoderm long non-coding RNA (HIDEN).